Interestingly, other ABC transporter genes that have been described to confer resistance in cell lines with acquired doxorubicin (e.g., ABCC1, ABCC2, and ABCG2) were not related to inherent anthracycline resistance in this panel of tumor cell lines. The gene discussed is ABCC2; the disease is neoplasm.